Sarah Danson
@sdanson1.bsky.social
2.7K followers 1.1K following 51 posts
Professor of Medical Oncology (melanoma and early phase), Ex vivo Clinical Lead & School Director of Research, Sheffield, UK
Posts Media Videos Starter Packs
sdanson1.bsky.social
Great to see @greg-wells.bsky.social and @ljtl.bsky.social on behalf of the Sheffield ex vivo group. Well done!
Reposted by Sarah Danson
ithinkwellhugh.bsky.social
Longer hours. But why?
#PhDchat #PhDforum #ECRchat #postdoc
Reposted by Sarah Danson
trishgreenhalgh.bsky.social
PREPRINT CLAIMING LINK BETWEEN mRNA VACCINES A D CANCER HAS BEEN WITHDRAWN. Thanks @elisabethbik.bsky.social for your vigilance.
elisabethbik.bsky.social
Preprint claiming link between COVID-19 mRNA vaccines and 'transcriptomic dysregulation'/cancer (based on just 10 people who got cancer in the year after vaccination) has been withdrawn.

HT: @reeserichardson.bsky.social

preprints.org/manuscript/2...
See: scienceintegritydigest.com/2025/07/25/p...
Screenshot from https://www.preprints.org/manuscript/202507.2155/v1 showing the title of the paper with the word Withdrawn marked in red. Full text visible in the screenshot:

"This preprint has been withdrawn
Preprint - Article - This version is not peer-reviewed.

Withdrawn: Synthetic mRNA Vaccines and Transcriptomic Dysregulation: Evidence from New-Onset Adverse Events and Cancers Post-Vaccination
Natalia von Ranke,Wei Zhang,Philipp Anokin,Nicolas Hulscher,Kevin J. McKernan,Peter A. McCullough,John A. Catanzaro  *

Withdrawal Statement
This preprint has unresolved ethical issues."
sdanson1.bsky.social
We are open to recruitment in Sheffield
melanomafocus.bsky.social
The DETECTION-2 trial is using targeted blood tests to check for relapse following surgery for patients with resected stage 2B/2C/3A melanoma of the skin.

The trial is recruiting at 12 hospitals across the UK. Watch this video to learn more👉 buff.ly/2yi71QV

#melanoma
Reposted by Sarah Danson
sheffielduni.bsky.social
The National Student Survey results are in and we're proud to say that we're top of the Russell Group for the third year in a row! And our Student's Union has been ranked number 1 once again.

A testament to the hard work of our brilliant University community 👏🎉

sheffield.ac.uk/news/sheffie...
The Arts Tower with trees and Weston Park in the foreground
Reposted by Sarah Danson
Reposted by Sarah Danson
greg-wells.bsky.social
Impressive poster from Dr Sophie Williams @sheffielduni.bsky.social on the microenvironment in GBM. Also her Supervisor @sdanson1.bsky.social #SMPHResearch&Innovation
sdanson1.bsky.social
This is superb news. Something to really celebrate. Thanks to all involved
sheffielduni.bsky.social
The QS World University Rankings 2026 have just been released and we’ve placed 92nd within the World Top 100! Huge congratulations and thanks to everyone in the University of Sheffield community for this achievement; from staff and students to alumni, supporters and friends around the world!
A graphic of an outline of a shield filled with photographs of students, teachers, academics and other members of the University of Sheffield community. The QS logo is prominently displayed near the bottom of the shield. Underneath is written ‘The University of Sheffield Top 100 QS World University Rankings 2026’
sdanson1.bsky.social
Great work from Sophie Williams on brain ageing in the glioblastoma tumour microenvironment
sdanson1.bsky.social
Sheffield Ex Vivo Group out in force at Sheffield #smph_research&innovation meeting today. Callum Blee, Louis Lane and Jamie Adams pictured. Great to see
Reposted by Sarah Danson
cruk-mi.bsky.social
We are delighted to announce, along with Cancer Research UK (@cancerresearchuk.org), The University of Manchester (@manchester.ac.uk) and The Christie NHS Foundation Trust, the appointment of Professor Samra Turajlić as our new Director! ⭐

Full story here: www.cruk.manchester.ac.uk/news/profess...
Announcement image - dark blue background with coloured overlapping circles
 
Top shows the Cancer Research UK Manchester Institute Logo
 
Centre shows a photograph of Professor Samra Turajlić
 
Text says:
 
"A warm welcome to our new Director, Professor Samra Turajlić, from all staff and students at the Cancer Research UK Manchester Institute"
sdanson1.bsky.social
Enjoyed today. Looking forward to hearing more tomorrow
insigneoinstitute.bsky.social
We're at @sheffielduni.bsky.social's School of Medicine & Population Health #Research & #Innovation Meeting today.

Prof Christine Le Maitre kicked off the day with the welcome. Great to see so many from across the school gathered together to connect and share research.

#SMPH_Research&Innovation
sdanson1.bsky.social
Christine Le Maitre opening our annual meeting #SMPH_Research&Innovation. Apologies I cannot rotate!!
Reposted by Sarah Danson
erainerolab.bsky.social
Exciting opportunity to join the cancer research community in Sheffield!!
mcb-sheffield.bsky.social
📣 Postdoctoral position available!!!
Are you interested in translating molecular cell biology into potential cancer therapy?
This project will explore the role of EGFR trafficking in chemotherapy resistance in #breastcancer
🔬 Prof Liz Smythe lab
📅 Deadline: 3rd Jule
👇 www.jobs.ac.uk/job/DNJ622/r...
Research Associate (Cell Biology) at University of Sheffield
An opportunity for an academic position as a Research Associate (Cell Biology) is available, as advertised on jobs.ac.uk. Apply now and explore other academic job openings.
www.jobs.ac.uk
sdanson1.bsky.social
Didn't I just see you in person??
Reposted by Sarah Danson
melanomafocus.bsky.social
Yesterday, Professor Sarah Danson presented the results of the UK DANTE trial at the 2025 American Society of Clinical Oncology (ASCO) annual medical meeting.

Read more: buff.ly/arneMoo

#melanoma #melanomacancer #ASCO25
sdanson1.bsky.social
Honoured to present the DANTE trial at ASCO today on behalf of the extended DANTE team. Thank you to all the patients who were involved
Reposted by Sarah Danson
funchainmd.bsky.social
Much less clarity on whether or not to continue systemic immunotherapy after pCR following neoadjuvant therapy

The people have spoken, and they are undedecided - more work to do! #melsm #ASCO25
sdanson1.bsky.social
Great to meet up with Sheffield colleagues, Sophie Trotter and Syed Hussain at #ASCO25
sdanson1.bsky.social
Sophie Trotter at #ASCO25 presenting frailty measures from the STAR renal cell cancer trial @fohsheffield.bsky.social @sheffieldteachinghospitals @universityofleeds.bsky.social
Reposted by Sarah Danson
pearlf.bsky.social
Data from randomized Ph 3 trial that studied time of day of immunotherapy infusion said that infusion before 3:00 PM is far superior to > 3:00 PM. Study by Yongchang Zhang & team. Circadian rhythms with potential major impact on T cell circulation & exhaustion. h/t @stephenvliu.bsky.social #ASCO25
Reposted by Sarah Danson
funchainmd.bsky.social
Phase II ipi nivo rela with IL6 inhibitor sarilumab with ORR 68% - highest reported with IO - and grade 3/4 irAEs 12% - lowest reported with combination IO
Jan Mehnert @nyulangone.bsky.social
#ASCO25 @ascocancer.bsky.social @aspire-cop.bsky.social
Reposted by Sarah Danson
funchainmd.bsky.social
Melanoma rapid #3 ➡️ High fiber diet of 30-50g daily is tolerable, pCR 57% in neoadj group, grade 3+ irAE 28.8%

Took 400 patients screened to enroll 45 🤔

Yiufan Qiu @mdanderson.bsky.social
#ASCO25 @ascocancer.bsky.social
@aspire-cop.bsky.social
Reposted by Sarah Danson
funchainmd.bsky.social
Metastatic mucosal melanoma today:
-combination immunotherapy shows lackluster efficacy
-MEKi with 25% ORR
-KIT + anti PD1 with 54.8% ORR
-triplet ICI with 33% ORR
-lenv pembro with 50% ORR
-TIL with 50% ORR
Jun Guo
#ASCO25 #raremelanoma #rarecancers @ascocancer.bsky.social